Recombinant NCAM1 (Lorvotuzumab Biosimilar) antibody

Catalog No. ABIN7597798

The Humanized Chimeric anti-NCAM1 (Lorvotuzumab Biosimilar) antibody has been validated for . It is suitable to detect NCAM1 (Lorvotuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant NCAM1 (Lorvotuzumab Biosimilar) antibody (ABIN7597798)

Target: NCAM1 (Lorvotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This NCAM1 (Lorvotuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-NCAM1 (Lorvotuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Lorvotuzumab Biosimilar Antibody

Specificity: NCAM-1, NCAM1, CD56, N-CAM-1, NCAM, Neural cell adhesion molecule 1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for NCAM1 (Lorvotuzumab Biosimilar)

Target: NCAM1 (Lorvotuzumab Biosimilar)

Alternative Name: Lorvotuzumab Biosimilar

Target Type: Biosimilar

Background: NCAM-1, NCAM1, CD56, N-CAM-1, NCAM, Neural cell adhesion molecule 1

UniProt: P13591

CAS-No: 1008106-64-6